Asston Pharmaceuticals Limited has disclosed an increase in promoter group shareholding, as reported on August 31, 2026. Mrs. Prakruti R Pali, part of the promoter group, acquired an additional 2.82% stake in the company through open market transactions. This acquisition brings the total promoter holding to 5.33% of the equity share capital, signaling increased confidence in the company’s prospects.
Promoter Stake Increase
Asston Pharmaceuticals Limited has filed a disclosure detailing a significant increase in shareholding by a promoter group entity. Mrs. Prakruti R Pali, acting as the acquirer, has acquired additional shares of the company. This transaction took place on August 31, 2026, via open market purchases.
Acquisition Details
Prior to this acquisition, the holding of shares carrying voting rights by the promoter group was 2.51%, representing 2,14,000 equity shares. Following the acquisition of 2,40,000 equity shares, the total holding of shares carrying voting rights has increased to 5.33%, amounting to 4,54,000 equity shares. The acquisition was executed in the open market and the shares acquired are fully paid up equity shares.
Company Capital Structure
The equity share capital and total voting capital of Asston Pharmaceuticals Limited stood at 2,14,000 Equity Shares before this acquisition. Post-acquisition, the equity share capital and total voting capital have increased to 4,54,000 Equity Shares.
Source: BSE
